Arsenic trioxide ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice by inducing CD4+ T cell apoptosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Arsenic trioxide ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice by inducing CD4+ T cell apoptosis ; volume:17 ; number:1 ; day:6 ; month:5 ; year:2020 ; pages:1-14 ; date:12.2020
Journal of neuroinflammation ; 17, Heft 1 (6.5.2020), 1-14, 12.2020
- Creator
-
An, Ke
Xue, Meng-Jiao
Zhong, Jia-Ying
Yu, Sheng-Nan
Lan, Tian-Shu
Qi, Zhong-Quan
Xia, Jun-Jie
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12974-020-01829-x
- URN
-
urn:nbn:de:101:1-2020071321214959235618
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- An, Ke
- Xue, Meng-Jiao
- Zhong, Jia-Ying
- Yu, Sheng-Nan
- Lan, Tian-Shu
- Qi, Zhong-Quan
- Xia, Jun-Jie
- SpringerLink (Online service)
Other Objects (12)
PML-RARA mutations confer varying arsenic trioxide resistance
Arsenic trioxide uptake by hexose permeases in Saccharomyces cerevisiae
Oxidative stress induced by the chemotherapeutic agent arsenic trioxide
Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
Metal–organic framework nanoparticles for arsenic trioxide drug delivery
Arsenic trioxide as a novel anti-glioma drug: a review
Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse
Classification of acute myeloid leukemia as a ferroptosis-sensitive malignancy suggesting the development of arsenic trioxide mediated ferroptosis-inducing combination therapies
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9
PML and its degradation by arsenic trioxide in interferon-mediated neuro-inflammation
PML-RARA mutations confer varying arsenic trioxide resistance
Arsenic trioxide uptake by hexose permeases in Saccharomyces cerevisiae
Oxidative stress induced by the chemotherapeutic agent arsenic trioxide
Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
Metal–organic framework nanoparticles for arsenic trioxide drug delivery
Arsenic trioxide as a novel anti-glioma drug: a review
Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse
Classification of acute myeloid leukemia as a ferroptosis-sensitive malignancy suggesting the development of arsenic trioxide mediated ferroptosis-inducing combination therapies
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9
PML and its degradation by arsenic trioxide in interferon-mediated neuro-inflammation
PML-RARA mutations confer varying arsenic trioxide resistance
Arsenic trioxide uptake by hexose permeases in Saccharomyces cerevisiae
Oxidative stress induced by the chemotherapeutic agent arsenic trioxide
Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
Metal–organic framework nanoparticles for arsenic trioxide drug delivery
Arsenic trioxide as a novel anti-glioma drug: a review
Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse
Classification of acute myeloid leukemia as a ferroptosis-sensitive malignancy suggesting the development of arsenic trioxide mediated ferroptosis-inducing combination therapies
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9